Sports Spin Unlocks Value, Much Already Captured

Size: px
Start display at page:

Download "Sports Spin Unlocks Value, Much Already Captured"

Transcription

1 August 1, :52 AM GMT The Madison Square Garden Company Sports Spin Unlocks Value, Much Already Captured Stock Rating Equal-weight Industry View In-Line Price Target $ The capital-intensive Sphere project may deliver a transformative experience to consumers, but it also increases uncertainty for MSG shareholders. The contemplated spin helps alleviate that uncertainty, while at the same time moving to capture more of the value of its iconic sports assets. WHAT'S CHANGED The Madison Square Garden From To Company (MSG.N) Price Target $ $ Spinning two birds with one stone: Our downgrade of MSG shares last year was a result of a significant narrowing of the discount to its sum-of-the-parts (SotP), combined with the shift the company was making in investment priorities towards big bets on venue expansion (see "MSG's Sphere a Long-Duration Bet on Technology & Live Entertainment"). The contemplated spin by MSG's board, not yet finalized but in our view plausible, could accomplish two related goals. First, creating a pure play publicly traded holding company of two marquee sports franchises in the Knicks and Rangers. This has already narrowed the gap between the public equity and the underlying private market value, and likely will continue to. Second, by parking ⅓ of the SportsCo in EntCo, it could move to monetize that stake and establish a valuation mark on those assets while at the same time raising needed capital to help fund and de-risk its Sphere bets. Three key assumptions drive our updated valuation: First, an appropriate discount to fair value for the sports teams to trade at inside SportsCo. Second, the right multiple on the EntCo EBITDA. Finally, tax treatment on the ⅓ stake of SportsCo held by EntCo. There are no perfect comps to either standalone company, but we see Liberty Braves (BATRK) as a reasonable starting point for the SportsCo. We estimate BATRK trades at a roughly 20% discount to its SotP, and its asset value is 65% the Atlanta Braves franchise and the remainder the Stadium and Battery, a surrounding mixed use real estate holding. On EntCo's multiple and post-spin EBITDA, there is clearly a wide range of reasonable assumptions. Live Nation may be the best publicly traded comp, although given the earnings power of Live Nation stems primarily from ticketing, it is imperfect. Finally, we have assumed the ⅓ stake in SportsCo is valued pre-tax inside EntCo. While a cash sale would trigger a taxable gain, we assume MSG will work to minimize or eliminate those taxes by utilizing its existing NOL and benefiting from the annual taxable depreciation of its Sphere project. MORGAN STANLEY & CO. LLC Benjamin Swinburne, CFA EQUITY ANALYST Benjamin.Swinburne@morganstanley.com Cameron Mansson-Perrone RESEARCH ASSOCIATE Cameron.Mansson-Perrone@morganstanley.com Madison Square Garden Co ( MSG.N, MSG US ) Media / United States of America Stock Rating Equal-weight Industry View In-Line Price target $ Shr price, close (Jul 31, 2018) $ Mkt cap, curr (mm) $7, Week Range $ Fiscal Year Ending 06/17 06/18e 06/19e 06/20e ModelWare EPS ($) (1.39) Prior ModelWare EPS ($) P/E NM Consensus EPS ($) (0.77) Div yld (%) Unless otherwise noted, all metrics are based on Morgan Stanley ModelWare framework = Consensus data is provided by Thomson Reuters Estimates e = Morgan Stanley Research estimates QUARTERLY MODELWARE EPS ($) 2018e 2018e 2019e 2019e Quarter 2017 Prior Current Prior Current Q1 (0.14) a - - Q a - - Q a - - Q4 (1.52) (0.24) (0.10) - - e = Morgan Stanley Research estimates, a = Actual Company reported data Morgan Stanley does and seeks to do business with companies covered in Morgan Stanley Research. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of Morgan Stanley Research. Investors should consider Morgan Stanley Research as only a single factor in making their investment decision. For analyst certification and other important disclosures, refer to the Disclosure Section, located at the end of this report. 1

2 Taking up our SoTP and estimates, raising PT to $315 but staying EW after 15% run over last month: Our revised base, bull, and bear cases are $315, $380, and $230. Our base case assumes the teams trade at a 15% discount to most recent Forbes value (tighter than BATRK due to potential sale of stake), and that the EntCo trades at 14x EV / base case EBITDA (broadly in-line with LYV) with roughly $ mm for excess value not captured in its earnings base. Our bull case assumes zero discount to Forbes, triggered by a hypothetical sale of ⅓ of the teams to a strategic investor, and 18x EV / bull case EBITDA for EntCo. Our bear case assumes the discount widens to 40%, as no sale is consummated for the ⅓ stake and the EntCo trades at 10x EV/bear case EBITDA. MSG shares are up ~15% since the close prior to announcing its spin consideration on June 27. With a fairly balanced risk/reward, we see other options in Media we prefer and will reassess MSG as we learn more about the spin specifics. Process from here: The MSG board must confirm it is moving ahead with the plan to spin off SportsCo, file a Form 10, and then hold a shareholder vote. Using past MSG spin-offs as proxies, the entire process is likely to take months from first announcement - or until April/May of

3 Risk Reward MSG Current Trading Level vs. Base, Bull, and Bear Cases $ 400 Investment Thesis $ (+22%) 350 We estimate that MSG's sports teams and $ $ (+1%) venue assets currently collectively trade at a 300 near 20% discount to private market value, 250 tight historically given expectations for the $ (-26%) 200 spin-off of the Sports business. While we believe upcoming venue investments around 150 Sphere and new launches at TAO create room 100 for value creation from here, they also bring 50 uncertainty and drive a balanced risk/reward, in our view. 0 Jul-16 Jan-17 Jul-17 Jan-18 Jul-18 Jan-19 Jul-19 Source: Company data, Morgan Stanley Research Price Target (Jul-19) Historical Stock Performance Current Stock Price WARNINGDONOTEDIT_RRS4RL~MSG.N~ Price Target $315 Our FYE19 price target is based on our base case valuation. It is over twice our DCF-driven FMV, reflecting the higher private market value of MSG's sports teams / venue assets. Bull $380 No discount to teams private mkt value, EntCo at 18x EV / fwd EBITDA Successful sale of all or part of proposed Sports Co. closes discount to private market value: MSG announces a sale of 'trophy' assets (Knicks, Rangers, Garden), or other action that market sees paving way to a sale. This fully closes teams discount to estimated private market value. Healthy growth at EntCo drives improved outlook and positivity around Sphere investments and results in 18x fwd. EBITDA multiple in our bull case. Base $315 Teams at ~15% discount to private mkt value, EntCo at 14x EV / fwd EBITDA Sports/Ent. trades at ~15% discount to private market value: Lacking further catalysts to fully close the gap, the spin-off nevertheless tightens the teams' discount to private value to ~15% on higher perceived likelihood of asset monetization and increased simplicity of asset portfolio. The Entertainment company grows adj. EBITDA at an avg. CAGR of ~20% over the next five years, and trades at 14x EV / fwd. EBITDA. Bear $230 Teams at ~40% disc. to private mkt value, Ent at 10x EV / fwd EBITDA No spin-off, discount to private market value widens to ~40%: The proposed spin-off does not occur and teams trade at a ~40% discount to private value, reflecting reduced optimism for a monetization event in the near-term. Market concern surrounding the company's investment plans at the Entertainment company drive it to trade at 10x EV / fwd. EBITDA. Key Value Drivers Our PT assumes the current NAV discount tightens over the next year. The proposed asset spin would likely be perceived as precursors to tax-efficient asset monetization, which could narrow the discount. NBA / NHL team value estimates will likely be driven by future team sales. While visibility is low, we see potential for healthy growth here, particularly with regard to sponsorship. MSG had a ~$1.1 bn net cash balance at CYE17. A large share of this is slated to be used towards the company's Sphere projects. Success / failure with these projects could create / destroy value. Potential Catalysts Successful execution of MSG Sphere investments. Strong team performance or comparable team sales could lift perceived team values. Corporate actions (spins, sales, etc.) could close the estimated discount to private market value. Risks to Achieving Price Target MSG invests in unsuccessful venues; poor team performance or comparable team sales at lower than expected values; consumer downturn could hurt live entertainment industry, depressing venue values; higher Knicks payroll could drive higher luxury tax penalties, diminishing Sports profitability. 3

4 Sum-of-the-Parts Analysis We are raising our price target from $260 to $315. Driving this increase is a reduction of our assumed discount on the two marquee sports franchises, the Knicks and the Rangers, from 30% to 15% following the announced spin consideration. Summary of Assumptions: (1) Teams: Our estimates for the value of the teams are based on the most recent Forbes estimates. We then assume that the teams trade at a discount of ~15%, modestly tighter than our expectations for Liberty Braves (BATRK), which also owns underlying sports assets. The tighter discount is due to (a) higher expectations for a near-term monetization event and (b) pure-play team assets vs. real estate holdings at Braves. (2) Entertainment multiple: Our base case reflects an estimate of the Entertainment business' EV assuming an EV/fwd. EBITDA mulitple of 14x, broadly consistent with Live Nation (LYV, not covered). Other potential trading comps include Liberty Formula One (FWONK) and Lionsgate (LGFb), which trade at 27x times and 16.5x times EV/fwd. EBITDA, respectively. (3) Sports lease payment: Our EBITDA estimates for the proposed Entertainment business reflect revenue from the fair market lease the Sports company would need to pay the Garden on behalf of the Knicks and Rangers, which we estimate would have been $7 mm in FY18. (4) Excess value of Garden: We include ~20% of the estimated value for the Garden, or $ mm, of excess value related to the company's air rights. (5) MSG Sphere: For the time being, we conservatively value MSG Sphere at cost, reflecting estimated related capital expenditures through FYE19. (6) Cash: We estimate that subsequent to the proposed spin-off the Sports company would be allocated $200 mm of cash, with the remaining balance allocated to the Entertainment business. The company's press release stated that the Entertainment company would hold $1 billion in cash. Our estimate reflects our expectation for the $1.1 bn on the company's balance sheet at FYE18 to be reduced by both ~$480 mm of capex in FY19 as Sphere spending begins in earnest, and $200 mm of share repurchases. To the extent MSG raises additional debt to fund higher cash balance at spin for SportsCo, it is value neutral to MSG shares today. (7) Debt: We estimate no debt at the Sports company at FYE19 and no change to the current ~$100 mm of TAO-related debt at the Entertainment entity. 4

5 Exhibit 1: MSG Sum-of-the-Parts Analysis FYE19 MSG Sports Assets MSe Private MV ($M) Methodology New MSe Public MV ($M) Source NY Knicks (NBA) $3, % Discount $3,060.0 Forbes NY Rangers (NHL) 1, % 1,275.0 Forbes NY Liberty (WNBA) / Connecticut Whale (AHL) % 8.5 Forbes Enterprise Value $5, % $4,343.5 Plus: Cash & Equivalents $200.0 MSe allocated $200.0 MSe Less: Debt Less: Minority stake held at Ent. Co. (1,770.0) 14.0x EV/EBITDA (1,514.5) MSe Equity Value $3,540.0 $3,029.0 Dilutive Shares Outstanding SportsCo per Share $153 $131 MSG Entertainment Assets MSe Private MV ($M) Methodology New MSe Public MV ($M) MSG Arena & Complex (O&O) $1, % of Total $319.4 MSe Radio City/Beacon Theater (LT lease) + Rockettes franchise NA 0.0 Reflected in Chicago Theater (O&O) 26.9 NA 0.0 Consolidated L.A. Forum NA 0.0 MSG Sphere Cost MSe Total Venues $2,409.2 $804.5 Consolidated Operations NA 14.0x EV/EBITDA $1,221.7 MSe Plus: 33% Stake in MSG Sports $1,770.0 Pre-Tax Value $1,514.5 MSe Plus: Stakes in TAO & Boston Calling Cost Company data Enterprise Value $4,519.1 $3,880.5 Implied FYE19E fwd. EBITDA multiple 28.0x 24.1x Plus: Cash & unconsolidated assets $680.1 $680.1 Less: Debt ($105.4) ($105.4) Less: Boston Calling (49% minority interest) (131.2) (131.2) Less: TAO Group (37.5% minority interest) (15.2) (15.2) Less: Other Lilabilities (64.9) (64.9) Equity Value $4,882.5 $4,244.0 EntCo Per Share $212 $184 MSG per Share Value $365 $315 MSG Current Market Equity Value MSe Private MV ($M) New MSe Public MV ($M) Equity Value $7,201.0 $7,201.0 Per share $ $ Plus: Debt Less: Cash (665.4) (665.4) Plus: Boston Calling Minority (49%) Plus: TAO Group Minority (37.5%) Less: Other Assets (214.7) (214.7) MSG Current Market-Implied EV, FYE19 $6,572.7 $6,572.7 Implied FYE19E fwd. EBITDA multiple 40.8x 40.8x Implied Sports/Ent. EV Discount to Pvt Mkt Value -17% -3% Source: Company data, Forbes, NYC Department of Finance Assessment, Morgan Stanley Research Our EBITDA estimate for the pro forma Entertainment company assumes that total MSG corporate overhead is split equally between the Sports and Entertainment businesses. Additionally, it reflects the inclusion of lease revenue outlined above, and includes 10% of Sports segment EBITDA to account for a portion of economics that will change to the Entertainment business, per the company's press release. Exhibit 2: Estimated pro forma EBITDA for standalone Entertainment company FY18 FY19 FY20 FY21 FY22 Ent. Co. Segment EBITDA $99.3 $113.7 $115.7 $143.3 $175.1 Consolidated corporate overhead ($91.8) ($98.1) ($101.0) ($104.1) ($107.2) Percentage allocable to Ent. Co. 50% 50% 50% 50% 50% Less: Ent. Co allocable overhead ($45.9) ($49.0) ($50.5) ($52.0) ($53.6) Plus: Lease revenue from Sports Co. $7.0 $7.2 $7.4 $7.6 $7.9 Plus: SportsCo adj. EBITDA now at EntCo Pro forma Ent. Co. EBITDA $73.2 $87.0 $87.3 $114.0 $146.0 PF Growth % 19% 0% 31% 28% Source: Company data, Morgan Stanley Research 5

6 Prior vs. Current Exhibit 3: MSG Prior vs. Current Madison Square Garden In millions except per share FY4Q18 FY2018E FY2019E FY2020E Prior Current Change Prior Current Change Prior Current Change Prior Current Change MSG Entertainment Revenue $151 $ $735 $ $767 $ $789 $ % Growth 96% 100% +474bp 45% 48% +300bp 4% 4% (15)bp 3% 2% (56)bp Adj. EBITDA (2) Margin 0.6% 2.1% +151bp 15.2% 15.0% (21)bp 16.6% 16.3% (27)bp 16.7% 16.2% (51)bp MSG Sports Revenue $139 $138 (1) $787 $784 (3) $834 $832 (3) $866 $864 (3) % Growth -55% -55% (38)bp -3% -3% (32)bp 6% 6% +1bp 4% 4% +0bp Adj. EBITDA Margin 2.3% 3.1% +86bp 16.9% 18.3% +148bp 20.1% 20.1% +8bp 18.9% 18.9% +7bp Corporate, Eliminations and Other Revenue $0 $0 +0 ($0) ($0) (0) $0 $0 +0 $0 $0 +0 Adj. EBITDA ($20) ($19) +1 ($74) ($71) +2 ($78) ($76) +2 ($80) ($78) +2 MSG Consolidated Revenue $291 $ $1,522 $1, $1,601 $1, $1,656 $1, % Growth -5% -4% +82bp 15% 16% +95bp 5% 5% (7)bp 3% 3% (28)bp Adj. EBITDA (16) (11) Margin -5.5% -3.9% +159bp 11.2% 12.0% +82bp 13.5% 13.6% +8bp 13.0% 13.0% (5)bp % Growth 60% 14% (4,555)bp 30% 41% +1,071bp 27% 19% (809)bp -1% -2% (116)bp Stock-based comp (2) (2) (2) EBITDA (28) (24) Margin -10% -8% +163bp 8% 9% +98bp 10% 10% +23bp 10% 10% +10bp % Growth 36% 15% (2,197)bp 33% 51% +1,777bp 35% 23% (1,238)bp -2% -3% (144)bp D&A (1) (1) EBIT (59) (54) +5 (4) Margin -20% -19% +192bp 0% 1% +111bp 2% 2% +19bp 2% 2% +1bp Interest inc/(exp) (4) (4) +0 (9) (9) (0) Other income (0) (2) (1) Pre-tax income (58) (52) Taxes (2) (3) (10) (11) (1) (7) (7) (0) Net income (38) (34) Net income (minority adj.) (39) (36) CapEx FCF N/A N/A N/A (40) (52) (12) (323) (335) (12) (385) (400) (15) Per share N/A N/A N/A ($1.70) ($2.22) ($0.52) ($13.96) ($14.34) ($0.38) ($17.12) ($17.50) ($0.38) EPS (adj.) ($1.64) ($1.50) +$0.15 $5.81 $6.58 +$0.77 $0.66 $0.76 +$0.11 $0.34 $0.36 +$0.02 Source: Company data, Morgan Stanley Research 6

7 Bull/Bear/Base Case Estimates Exhibit 4: MSG Operating Bull/Bear/Base Estimates MSG Scenarios Base Case Bear Case Bull Case ($ millions) FY18E FY19E FY20E ($ millions) FY18E FY19E FY20E ($ millions) FY18E FY19E FY20E EPS $6.58 $0.76 $0.36 EPS $5.55 ($1.10) ($0.91) EPS $6.64 $1.23 $1.61 Growth % 275.3% -88.4% -52.8% Growth % 216.5% % -17.3% Growth % 278.6% -81.5% 31.4% Revenue 1,534 1,614 1,664 Revenue 1,527 1,581 1,636 Revenue 1,538 1,634 1,692 Growth % 16.4% 5.2% 3.1% Growth % 15.8% 3.5% 3.5% Growth % 16.6% 6.2% 3.6% Operating Expenses ,008 Operating Expenses ,022 Operating Expenses Growth % 13.7% 3.6% 4.6% Growth % 17.4% 3.4% 2.8% Growth % 13.9% 3.9% 2.8% SG&A SG&A SG&A Growth % 13.6% 2.7% 2.2% Growth % 13.6% 2.7% 2.2% Growth % 13.6% 2.7% 2.2% Total Expenses 1,349 1,394 1,448 Total Expenses 1,379 1,424 1,461 Total Expenses 1,351 1,399 1,436 Growth % 13.7% 3.3% 3.9% Growth % 16.2% 3.2% 2.7% Growth % 13.8% 3.6% 2.6% Adj. EBITDA Adj. EBITDA Adj. EBITDA Growth % 40.8% 18.6% -1.7% Growth % 12.5% 6.5% 11.0% Growth % 42.4% 25.7% 9.3% Margin % 12.0% 13.6% 13.0% Margin % 9.7% 9.9% 10.7% Margin % 12.2% 14.4% 15.2% EBITDA EBITDA EBITDA Growth % 50.6% 23.0% -3.4% Growth % 9.3% 6.5% 14.7% Growth % 52.9% 32.4% 11.0% Margin % 8.8% 10.3% 9.7% Margin % 6.4% 6.6% 7.4% Margin % 9.0% 11.2% 12.0% EBIT EBIT (24) (22) (9) EBIT Growth % % 193.7% -19.5% Growth % 37.3% -5.6% -59.4% Growth % % 254.0% 32.4% Margin % 0.9% 2.5% 1.9% Margin % -1.6% -1.4% -0.6% Margin % 1.0% 3.4% 4.3% MSG Entertainment MSG Entertainment MSG Entertainment Total Revenue $750 $782 $800 Total Revenue $743 $749 $772 Total Revenue $754 $802 $829 Growth % 48.1% 4.2% 2.3% Growth % 46.7% 0.9% 3.1% Growth % 48.8% 6.4% 3.3% Adj. EBITDA Adj. EBITDA Adj. EBITDA Adj. EBITDA margin 15.0% 16.3% 16.2% Adj. EBITDA margin 14.6% 13.4% 13.7% Adj. EBITDA margin 15.2% 17.8% 18.2% MSG Sports MSG Sports MSG Sports Total Revenue $784 $832 $864 Total Revenue $784 $832 $864 Total Revenue $784 $832 $864 Growth % -3.4% 6.1% 3.8% Growth % -3.4% 6.1% 3.8% Growth % -3.4% 6.1% 3.8% Adj. EBITDA Adj. EBITDA Adj. EBITDA Adj. EBITDA margin 18.3% 20.1% 18.9% Adj. EBITDA margin 14.1% 15.9% 17.0% Adj. EBITDA margin 18.3% 20.1% 21.3% Other Items Other Items Other Items Capex $184 $496 $550 Capex $184 $495 $549 Capex $185 $496 $551 Gross Debt / Adj. EBITDA 0.6x 0.5x 0.5x Gross Debt / Adj. EBITDA 0.7x 0.7x 0.6x Gross Debt / Adj. EBITDA 0.6x 0.4x 0.4x Net Debt / Adj. EBITDA (5.6)x (2.6)x (0.1)x Net Debt / Adj. EBITDA (6.9x) (3.2x) 0.2x Net Debt / Adj. EBITDA (5.6x) (2.2x) 0.1x Free Cash Flow ($52) ($335) ($400) Free Cash Flow ($83) ($397) ($441) Free Cash Flow ($51) ($320) ($360) FCF/Share ($2.22) ($14.34) ($17.50) FCF/Share ($3.54) ($17.02) ($19.41) FCF/Share ($2.17) ($13.70) ($15.75) Normalized FCF/Share ($3.85) ($16.02) ($19.25) Normalized FCF/Share ($5.17) ($18.70) ($21.17) Normalized FCF/Share ($3.80) ($15.38) ($17.50) SOTP SportsCo Discount -15% -40% 0% SportsCo Equity $3,029.0 $2,177.3 $3,540.0 SportsCo Share Price $131 $95 $153 EntCo Multiple 14.0x 10.0x 18.0x EntCo EBITDA $87.3 $61.4 $110.1 EntCo EV $3,880.5 $2,846.8 $4,895.5 EntCo Equity $4,244.0 $3,158.9 $5,224.3 EntCo Share Price $184 $138 $226 Implies SOTP Target Price $315 $232 $380 Price Target $315 $230 $380 Current Price $312 $312 $312 Upside 1% -26% 22% Source: Company data, Morgan Stanley Research; Note: FYE June 30 7

8 Exhibit 5: MSG Multiples Analysis Current Price Target Price 2018E 2019E 2020E 2018E 2019E 2020E MSG - Stock Price $ $ $ $ $ $ Class A Common Stock - Dilutive Shares Out Class B Common Stock - Dilutive Shares Out Total Market Value $7,392.3 $7,201.0 $7,065.9 $7,462.6 $7,269.5 $7,133.2 Plus: Year End Debt $105.4 $105.4 $105.4 $105.4 $105.4 $105.4 Minority interest - Boston Calling (49%) Minority interest - TAO Group (37.5%) Less: Cash 1, , Unconsolidated/ Other Assets Unconsolidated/ Other Assets Total Other Assets Enterprise Value $6,289.6 $6,572.7 $6,973.8 $6,360.0 $6,641.3 $7,041.0 EBITDA (adj) $135.7 $166.9 $161.3 $135.7 $166.9 $161.3 EV / EBITDA 46.4x 39.4x 43.2x 46.9x 39.8x 43.7x Forward EBITDA (adj) $166.9 $161.3 $190.2 $166.9 $161.3 $190.2 EV / Forward EBITDA 37.7x 40.8x 36.7x 38.1x 41.2x 37.0x Unlevered Free Cash Flow ($94.1) ($372.5) ($435.0) ($94.1) ($372.5) ($435.0) EV / Unlevered FCF NM NM NM NM NM NM Forward Unlevered Free Cash Flow ($372.5) ($435.0) ($418.7) ($372.5) ($435.0) ($418.7) EV / Fwd. Unlevered FCF NM NM NM NM NM NM FCF ($90.8) ($374.6) ($440.1) ($90.8) ($374.6) ($440.1) Adj. P / FCF NM NM NM NM NM NM Forward FCF ($374.6) ($440.1) ($431.7) ($374.6) ($440.1) ($431.7) Adj. P / FCF (Fwd) NM NM NM NM NM NM Adj. EPS $6.58 $0.76 $0.36 $6.58 $0.76 $0.36 Adj. P / E 47.4x 408.2x 865.7x 47.9x 412.1x 874.0x Forward Adj. EPS $0.76 $0.36 $0.15 $0.76 $0.36 $0.15 Adj. P / E (fwd) 408.2x 865.7x 2,093.4x 412.1x 874.0x 2,113.3x Source: Company data, Morgan Stanley Research; Note: FYE June 30 Exhibit 6: MSG Free Cash Flow Analysis (in millions) 2016A 2017A 2018E 2019E 2020E 2021E EBITDA (adj.) $85.7 $90.1 $135.7 $166.9 $161.3 $190.2 Net Interest Income (Expense) (3.5) (8.6) (21.7) Capital Expenditures (71.7) (44.2) (184.5) (495.8) (549.8) (556.4) Cash Taxes (5.5) 0.0 (6.0) Increase in Working Capital (3.0) (3.0) (3.0) (3.0) Free Cash Flow $100.7 $164.4 ($52.3) ($335.4) ($400.1) ($390.9) Avg. Fully Diluted Shares FCF / Share $4.07 $6.89 ($2.22) ($14.34) ($17.50) ($17.46) Growth % 124.5% 69.6% % NM NM NM Normalized FCF / Share $2.57 $5.31 ($3.85) ($16.02) ($19.25) ($19.28) Growth % 164.9% 106.5% % NM NM NM Adj. EPS / Share $0.83 $1.75 $6.58 $0.76 $0.36 $0.15 Growth % NM 110.8% 275.3% -88.4% -52.8% -58.6% Unlevered FCF $97.9 $159.8 ($55.6) ($333.3) ($395.0) ($377.9) Unlevered FCF / Share $3.95 $6.70 ($2.36) ($14.25) ($17.28) ($16.88) % Change 116.5% 69.6% % NM NM NM Normalized Unlevered FCF $60.9 $122.1 ($94.1) ($372.5) ($435.0) ($418.7) Normalized Unlevered FCF / Share $2.46 $5.12 ($3.99) ($15.93) ($19.03) ($18.70) % Change 149.5% 108.3% % NM NM NM Source: Company data, Morgan Stanley Research; Note: FYE June 30 8

9 Exhibit 7: MSG Income Statement, Annual US$ Millions 2016A 2017A 2018E 2019E 2020E 2021E Madison Square Garden: Income Statement Total Revenues 1, , , , , ,876.5 Operating Costs (OpEx + SG&A) 1, , , , , ,630.1 Total adj. EBITDA Share-Based Comp Expense Other Expense: Restructuring, etc Total EBITDA Depreciation and amortization Operating income (loss) (16.8) (17.3) Other income (expense): Interest income (expense), net (3.5) (8.6) (21.7) Miscellaneous (64.9) (71.6) (1.7) Income (loss) from operations before income taxes (77.0) (81.2) Income tax benefit (expense) (0.3) (10.8) (7.0) (5.2) Income Tax Rate 0% 5% -779% 30% 30% 30% Current Taxes (5.5) 0.0 (6.0) Net income (loss) - company level (77.3) (76.8) Minority interest (7.4) (8.1) (8.7) Net income (loss) (77.3) (72.7) Basic EPS ($3.12) ($3.05) $6.46 $0.77 $0.36 $0.15 Diluted EPS ($3.12) ($3.05) $6.45 $0.76 $0.36 $0.15 Less: Non-recurring income (expense) per share ($3.95) ($4.80) ($0.13) $0.00 $0.00 $0.00 Diluted EPS, Adj. for Consensus $0.83 $1.75 $6.58 $0.76 $0.36 $0.15 Plus: Amortization per share $0.27 $0.33 $0.87 $0.87 $0.85 $0.75 Plus: Tax Impact from Amortization per share ($0.11) ($0.13) ($0.30) ($0.26) ($0.25) ($0.23) ModelWare EPS, Diluted $0.99 $1.95 $7.14 $1.37 $0.95 $0.67 MSG Class A Shares (from B/S) MSG Class B Shares (from B/S) Unvested RSUs (0.0) (0.1) 0.0 (0.1) 0.0 (0.0) Period End Basic Shares Out Dilutive Options & RSUs (Treasury Method) Period End Diluted Shares Out Avg Basic Shares Out Avg Fully Diluted Shares Out Source: Company data, Morgan Stanley Research; Note: FYE June 30 9

10 Exhibit 8: MSG Income Statement, Quarterly US$ Millions 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 Madison Square Garden: Income Statement Total Revenues Operating Costs (OpEx + SG&A) Total adj. EBITDA (9.9) (11.3) Share-Based Comp Expense Other Expense: Restructuring, etc Total EBITDA (6.7) (20.6) (23.6) Depreciation and amortization Operating income (loss) (32.8) (49.4) - (14.5) (54.3) Other income (expense): Interest income (expense), net Miscellaneous (1.0) 0.2 (26.3) (44.5) (4.0) (1.4) 0.0 Income (loss) from operations before income taxes (31.8) 60.7 (17.4) (92.6) - (10.1) (52.3) Income tax benefit (expense) 2.9 (3.2) (0.4) (0.8) (0.7) 18.3 Income Tax Rate 9.2% 5.4% -2.5% 5.6% -7.5% % 7.7% 35.0% Net income (loss) - company level (28.914) (17.8) (87.5) - (10.9) (34.0) Minority interest (0.2) (1.6) Net income (loss) (28.6) 57.7 (17.5) (84.3) - (11.1) (35.6) Basic EPS ($1.19) $2.41 ($0.74) ($3.58) ($0.47) $8.03 $0.39 ($1.51) Diluted EPS ($1.19) $2.39 ($0.74) ($3.58) ($0.47) $7.96 $0.38 ($1.50) Less: Non-recurring income (expense) per share ($0.07) $0.01 ($1.77) ($3.02) $0.25 ($0.28) ($0.10) $0.00 Diluted EPS, Adj. for Consensus ($1.12) $2.38 $1.03 ($0.55) ($0.72) $8.24 $0.48 ($1.50) Plus: Amortization per share $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 Plus: Tax Impact from Amortization per share ($0.03) ($0.03) ($0.03) ($0.03) ($0.03) ($0.03) ($0.03) ($0.03) ModelWare EPS, Diluted ($1.08) $2.43 $1.08 ($0.50) ($0.67) $8.29 $0.54 ($1.44) MSG Class A Shares (from B/S) MSG Class B Shares (from B/S) Unvested RSUs (0.1) Period End Basic Shares Out Dilutive Options & RSUs (Treasury Method) Period End Diluted Shares Out Avg Basic Shares Out Avg Fully Diluted Shares Out Source: Company data, Morgan Stanley Research; Note: FYE June 30 10

11 Exhibit 9: MSG Balance Sheet US$ Millions 2016A 2017A 2018E 2019E 2020E 2021E Current Assets: Cash and cash equivalents 1, , , Restricted cash Accounts receivable Net receivable due from Cablevision Prepaid expenses Other current assets Total current assets 1, , , Advances due from Cablevision Property and equipment, net of accumulated depreciation 1, , , , , ,492.5 Investments in affilliates Other assets Amortizable intangible assets, net of accumulated amortization Indefinite-lived intangible assets Goodwill Total Assets 3, , , , , ,914.3 Current Liabilities: Short-term debt Accounts payable Accrued liabilities: Employee related costs Other expenses Deferred revenue Total current liabilities Long-term debt Defined benefit and other postretirement obligations Other employee related costs Other liabilities Deferred tax liability Total liabilities , , , , ,629.1 Combined Group Equity: Paid-in capital 2, , , , , ,051.1 Retained earnings (75.7) (148.4) Accumulated other comprehensive loss (42.6) (34.1) Combined Group equity 2, , , , , ,285.2 Total Liabilities & Equity 3, , , , , ,914.3 Source: Company data, Morgan Stanley Research; Note: FYE June 30 11

12 Exhibit 10: MSG Cash Flow Statement US$ Millions 2016A 2017A 2018E 2019E 2020E 2021E Cash flows from operating activities: Net income (loss) (77.3) (76.8) Adjustments to reconcile net income (loss) to net cash provided by operating activities: Depreciation and amortization Share-based compensation expense allocations, net Cumulative effect of a change in accounting, net of tax Gain on sale of operating asset Gain on curtailment of pension plans Amortization of purchase accounting liability Loss on equity investment Deemed capital contribution / Other Provision for doubtful accounts Change in assets and liabilities: Account receivable, net (25.1) (20.4) (15.2) (4.5) (2.1) (14.0) Net receivable due from Cablevision (5.1) Prepaid expenses and other assets (34.4) 1.8 (19.8) (6.2) (3.2) (18.5) Accounts payable Accrued and other liabilities (66.8) (2.2) 39.5 Deferred revenue (81.4) (16.8) Deferred tax liability (139.8) Net cash provided by operating activities Cash flows from investing activities: Capital expenditures (71.7) (44.2) (184.5) (495.8) (549.8) (556.4) Proceeds from sale of fixed assets Restricted cash Payments for acquisition of assets or equity interests (44.0) (220.1) Net cash used in investing activities ($115.7) ($264.3) ($184.5) ($495.8) ($549.8) ($556.4) Cash flows from financing activities: Change In Debt (unfunded) Debt: Repayments Debt: Additional Borrowings Dividends Paid Sale of Common Stock (Repurchase)/ (Distributions) (105.7) (148.0) (31.8) (200.1) (200.0) (200.0) Advances to Cablevision Repayment of advances to Cablevision Principal payments on capital lease obligations Deferred financing costs Capital contributions / Other 1,525.7 (10.6) Net cash provided by (used in) financing activities $1,420.0 ($158.5) ($31.8) ($200.1) ($200.0) $315.2 Net increase (decrease) in cash and cash equivalents 1,430.1 (206.2) (89.7) (483.0) (545.9) (19.5) Cash and cash equivalents at beginning of year , , , Cash and cash equivalents at end of year 1, , , Source: Company data, Morgan Stanley Research; Note: FYE June 30 Exhibit 11: MSG Capital Expenditures US$ Millions 2016A 2017A 2018E 2019E 2020E 2021E Segment-Level Capital Expenditures MSG Entertainment MSG Sports Total Segment-Level CapEx Corporate-Level Capital Expenditures General Corporate Garden Renovations LA Forum / MSG Sphere Total Corporate-Level CapEx Total Capital Expenditures CapEx as % of Revenue MSG Entertainment 1.2% 2.3% 3.3% 2.5% 2.8% 2.8% MSG Sports 0.7% 0.3% 0.5% 0.5% 0.5% 0.5% Source: Company data, Morgan Stanley Research; Note: FYE June 30 12

13 Disclosure Section The information and opinions in Morgan Stanley Research were prepared by Morgan Stanley & Co. LLC, and/or Morgan Stanley C.T.V.M. S.A., and/or Morgan Stanley Mexico, Casa de Bolsa, S.A. de C.V., and/or Morgan Stanley Canada Limited. As used in this disclosure section, "Morgan Stanley" includes Morgan Stanley & Co. LLC, Morgan Stanley C.T.V.M. S.A., Morgan Stanley Mexico, Casa de Bolsa, S.A. de C.V., Morgan Stanley Canada Limited and their affiliates as necessary. For important disclosures, stock price charts and equity rating histories regarding companies that are the subject of this report, please see the Morgan Stanley Research Disclosure Website at or contact your investment representative or Morgan Stanley Research at 1585 Broadway, (Attention: Research Management), New York, NY, USA. For valuation methodology and risks associated with any recommendation, rating or price target referenced in this research report, please contact the Client Support Team as follows: US/Canada ; Hong Kong ; Latin America (U.S.); London +44 (0) ; Singapore ; Sydney +61 (0) ; Tokyo +81 (0) Alternatively you may contact your investment representative or Morgan Stanley Research at 1585 Broadway, (Attention: Research Management), New York, NY USA. Analyst Certification The following analysts hereby certify that their views about the companies and their securities discussed in this report are accurately expressed and that they have not received and will not receive direct or indirect compensation in exchange for expressing specific recommendations or views in this report: Benjamin Swinburne, CFA. Unless otherwise stated, the individuals listed on the cover page of this report are research analysts. Global Research Conflict Management Policy Morgan Stanley Research has been published in accordance with our conflict management policy, which is available at Important US Regulatory Disclosures on Subject Companies As of June 29, 2018, Morgan Stanley beneficially owned 1% or more of a class of common equity securities of the following companies covered in Morgan Stanley Research: 21st Century Fox, CBS Corporation, Lions Gate Entertainment Corp., Madison Square Garden Co, MSG Networks Inc, Netflix Inc, Pandora Media Inc., Roku Inc., Spotify Technology SA, Viacom, Walt Disney Co. Within the last 12 months, Morgan Stanley managed or co-managed a public offering (or 144A offering) of securities of Liberty Braves Group, Liberty Formula One, Netflix Inc, Roku Inc.. Within the last 12 months, Morgan Stanley has received compensation for investment banking services from Interpublic Group, Lamar Advertising Co., Liberty Braves Group, Liberty Formula One, Netflix Inc, OUTFRONT MEDIA INC, Pandora Media Inc., Roku Inc., Spotify Technology SA, Viacom, Walt Disney Co. In the next 3 months, Morgan Stanley expects to receive or intends to seek compensation for investment banking services from 21st Century Fox, AMC Networks, Inc., CBS Corporation, Cinemark Holdings, Inc., Discovery Communications, Interpublic Group, Lamar Advertising Co., Liberty Braves Group, Liberty Formula One, Lions Gate Entertainment Corp., Madison Square Garden Co, MSG Networks Inc, Netflix Inc, Omnicom Group Inc., OUTFRONT MEDIA INC, Pandora Media Inc., Roku Inc., Spotify Technology SA, Viacom, Walt Disney Co, World Wrestling Entertainment Inc. Within the last 12 months, Morgan Stanley has received compensation for products and services other than investment banking services from AMC Networks, Inc., Cinemark Holdings, Inc., Discovery Communications, Interpublic Group, Lamar Advertising Co., Liberty Braves Group, Liberty Formula One, Spotify Technology SA, Walt Disney Co. Within the last 12 months, Morgan Stanley has provided or is providing investment banking services to, or has an investment banking client relationship with, the following company: 21st Century Fox, AMC Networks, Inc., CBS Corporation, Cinemark Holdings, Inc., Discovery Communications, Interpublic Group, Lamar Advertising Co., Liberty Braves Group, Liberty Formula One, Lions Gate Entertainment Corp., Madison Square Garden Co, MSG Networks Inc, Netflix Inc, Omnicom Group Inc., OUTFRONT MEDIA INC, Pandora Media Inc., Roku Inc., Spotify Technology SA, Viacom, Walt Disney Co, World Wrestling Entertainment Inc. Within the last 12 months, Morgan Stanley has either provided or is providing non-investment banking, securities-related services to and/or in the past has entered into an agreement to provide services or has a client relationship with the following company: AMC Networks, Inc., CBS Corporation, Cinemark Holdings, Inc., Discovery Communications, Interpublic Group, Lamar Advertising Co., Liberty Braves Group, Liberty Formula One, Netflix Inc, Pandora Media Inc., Spotify Technology SA, Walt Disney Co, World Wrestling Entertainment Inc. Morgan Stanley & Co. LLC makes a market in the securities of 21st Century Fox, AMC Networks, Inc., CBS Corporation, Cinemark Holdings, Inc., Discovery Communications, Interpublic Group, Lamar Advertising Co., Liberty Braves Group, Liberty Formula One, Madison Square Garden Co, MSG Networks Inc, Netflix Inc, Omnicom Group Inc., OUTFRONT MEDIA INC, Pandora Media Inc., Roku Inc., Viacom, Walt Disney Co, World Wrestling Entertainment Inc. The equity research analysts or strategists principally responsible for the preparation of Morgan Stanley Research have received compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors, firm revenues and overall investment banking revenues. Equity Research analysts' or strategists' compensation is not linked to investment banking or capital markets transactions performed by Morgan Stanley or the profitability or revenues of particular trading desks. Morgan Stanley and its affiliates do business that relates to companies/instruments covered in Morgan Stanley Research, including market making, providing liquidity, fund management, commercial banking, extension of credit, investment services and investment banking. Morgan Stanley sells to and buys from customers the securities/instruments of companies covered in Morgan Stanley Research on a principal basis. Morgan Stanley may have a position in the debt of the Company or instruments discussed in this report. Morgan Stanley trades or may trade as principal in the debt securities (or in related derivatives) that are the subject of the debt research report. Certain disclosures listed above are also for compliance with applicable regulations in non-us jurisdictions. STOCK RATINGS Morgan Stanley uses a relative rating system using terms such as Overweight, Equal-weight, Not-Rated or Underweight (see definitions below). Morgan Stanley does not assign ratings of Buy, Hold or Sell to the stocks we cover. Overweight, Equal-weight, Not-Rated and Underweight are not the equivalent of buy, hold and sell. Investors should carefully read the definitions of all ratings used in Morgan Stanley Research. In addition, since Morgan Stanley Research contains more complete information concerning the analyst's views, investors should carefully read Morgan Stanley Research, in its entirety, and not infer the contents from the rating alone. In any case, ratings (or research) should not be used or relied upon as investment advice. An investor's decision to buy or sell a stock should depend on individual circumstances (such as the investor's existing holdings) and other considerations. Global Stock Ratings Distribution (as of July 31, 2018) The Stock Ratings described below apply to Morgan Stanley's Fundamental Equity Research and do not apply to Debt Research produced by the Firm. For disclosure purposes only (in accordance with NASD and NYSE requirements), we include the category headings of Buy, Hold, and Sell alongside our ratings of Overweight, Equal-weight, Not-Rated and Underweight. Morgan Stanley does not assign ratings of Buy, Hold or Sell to the stocks we cover. Overweight, Equal-weight, Not-Rated and Underweight are not the equivalent of buy, hold, and sell but represent recommended relative weightings (see 13

14 definitions below). To satisfy regulatory requirements, we correspond Overweight, our most positive stock rating, with a buy recommendation; we correspond Equal-weight and Not-Rated to hold and Underweight to sell recommendations, respectively. STOCK RATING CATEGORY COVERAGE UNIVERSE INVESTMENT BANKING CLIENTS (IBC) OTHER MATERIAL INVESTMENT SERVICES CLIENTS (MISC) COUNT % OF TOTAL COUNT % OF TOTAL IBC % OF RATING CATEGORY COUNT % OF TOTAL OTHER MISC Overweight/Buy % % 26% % Equal-weight/Hold % % 27% % Not-Rated/Hold 49 2% 4 1% 8% 7 0% Underweight/Sell % 75 10% 14% % TOTAL 3, Data include common stock and ADRs currently assigned ratings. Investment Banking Clients are companies from whom Morgan Stanley received investment banking compensation in the last 12 months. Due to rounding off of decimals, the percentages provided in the "% of total" column may not add up to exactly 100 percent. Analyst Stock Ratings Overweight (O). The stock's total return is expected to exceed the average total return of the analyst's industry (or industry team's) coverage universe, on a risk-adjusted basis, over the next months. Equal-weight (E). The stock's total return is expected to be in line with the average total return of the analyst's industry (or industry team's) coverage universe, on a risk-adjusted basis, over the next months. Not-Rated (NR). Currently the analyst does not have adequate conviction about the stock's total return relative to the average total return of the analyst's industry (or industry team's) coverage universe, on a risk-adjusted basis, over the next months. Underweight (U). The stock's total return is expected to be below the average total return of the analyst's industry (or industry team's) coverage universe, on a risk-adjusted basis, over the next months. Unless otherwise specified, the time frame for price targets included in Morgan Stanley Research is 12 to 18 months. Analyst Industry Views Attractive (A): The analyst expects the performance of his or her industry coverage universe over the next months to be attractive vs. the relevant broad market benchmark, as indicated below. In-Line (I): The analyst expects the performance of his or her industry coverage universe over the next months to be in line with the relevant broad market benchmark, as indicated below. Cautious (C): The analyst views the performance of his or her industry coverage universe over the next months with caution vs. the relevant broad market benchmark, as indicated below. Benchmarks for each region are as follows: North America - S&P 500; Latin America - relevant MSCI country index or MSCI Latin America Index; Europe - MSCI Europe; Japan - TOPIX; Asia - relevant MSCI country index or MSCI sub-regional index or MSCI AC Asia Pacific ex Japan Index. Stock Price, Price Target and Rating History (See Rating Definitions) 14

15 Important Disclosures for Morgan Stanley Smith Barney LLC Customers Important disclosures regarding the relationship between the companies that are the subject of Morgan Stanley Research and Morgan Stanley Smith Barney LLC or Morgan Stanley or any of their affiliates, are available on the Morgan Stanley Wealth Management disclosure website at For Morgan Stanley specific disclosures, you may refer to Each Morgan Stanley Equity Research report is reviewed and approved on behalf of Morgan Stanley Smith Barney LLC. This review and approval is conducted by the same person who reviews the Equity Research report on behalf of Morgan Stanley. This could create a conflict of interest. Other Important Disclosures Morgan Stanley & Co. International PLC and its affiliates have a significant financial interest in the debt securities of AMC Networks, Inc., CBS Corporation, Interpublic Group, Netflix Inc, Omnicom Group Inc., Pandora Media Inc., Viacom, Walt Disney Co. Morgan Stanley Research policy is to update research reports as and when the Research Analyst and Research Management deem appropriate, based on developments with the issuer, the sector, or the market that may have a material impact on the research views or opinions stated therein. In addition, certain Research publications are intended to be updated on a regular periodic basis (weekly/monthly/quarterly/annual) and will ordinarily be updated with that frequency, unless the Research Analyst and Research Management determine that a different publication schedule is appropriate based on current conditions. Morgan Stanley is not acting as a municipal advisor and the opinions or views contained herein are not intended to be, and do not constitute, advice within the meaning of Section 975 of the Dodd-Frank Wall Street Reform and Consumer Protection Act. Morgan Stanley produces an equity research product called a "Tactical Idea." Views contained in a "Tactical Idea" on a particular stock may be contrary to the recommendations or views expressed in research on the same stock. This may be the result of differing time horizons, methodologies, market events, or other factors. For all research available on a particular stock, please contact your sales representative or go to Matrix at Morgan Stanley Research is provided to our clients through our proprietary research portal on Matrix and also distributed electronically by Morgan Stanley to clients. Certain, but not all, Morgan Stanley Research products are also made available to clients through third-party vendors or redistributed to clients through alternate electronic means as a convenience. For access to all available Morgan Stanley Research, please contact your sales representative or go to Matrix at Any access and/or use of Morgan Stanley Research is subject to Morgan Stanley's Terms of Use ( By accessing and/or using Morgan Stanley Research, you are indicating that you have read and agree to be bound by our Terms of Use ( In addition you consent to Morgan Stanley processing your personal data and using cookies in accordance with our Privacy Policy and our Global Cookies Policy ( including for the purposes of setting your preferences and to collect readership data so that we can deliver better and more personalized service and products to you. To find out more information about how Morgan Stanley processes personal data, how we use cookies and how to reject cookies see our Privacy Policy and our Global Cookies Policy ( If you do not agree to our Terms of Use and/or if you do not wish to provide your consent to Morgan Stanley processing your personal data or using cookies please do not access our research. Morgan Stanley Research does not provide individually tailored investment advice. Morgan Stanley Research has been prepared without regard to the circumstances and objectives of those who receive it. Morgan Stanley recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. The appropriateness of an investment or strategy will depend on an investor's 15

16 circumstances and objectives. The securities, instruments, or strategies discussed in Morgan Stanley Research may not be suitable for all investors, and certain investors may not be eligible to purchase or participate in some or all of them. Morgan Stanley Research is not an offer to buy or sell or the solicitation of an offer to buy or sell any security/instrument or to participate in any particular trading strategy. The value of and income from your investments may vary because of changes in interest rates, foreign exchange rates, default rates, prepayment rates, securities/instruments prices, market indexes, operational or financial conditions of companies or other factors. There may be time limitations on the exercise of options or other rights in securities/instruments transactions. Past performance is not necessarily a guide to future performance. Estimates of future performance are based on assumptions that may not be realized. If provided, and unless otherwise stated, the closing price on the cover page is that of the primary exchange for the subject company's securities/instruments. The fixed income research analysts, strategists or economists principally responsible for the preparation of Morgan Stanley Research have received compensation based upon various factors, including quality, accuracy and value of research, firm profitability or revenues (which include fixed income trading and capital markets profitability or revenues), client feedback and competitive factors. Fixed Income Research analysts', strategists' or economists' compensation is not linked to investment banking or capital markets transactions performed by Morgan Stanley or the profitability or revenues of particular trading desks. The "Important US Regulatory Disclosures on Subject Companies" section in Morgan Stanley Research lists all companies mentioned where Morgan Stanley owns 1% or more of a class of common equity securities of the companies. For all other companies mentioned in Morgan Stanley Research, Morgan Stanley may have an investment of less than 1% in securities/instruments or derivatives of securities/instruments of companies and may trade them in ways different from those discussed in Morgan Stanley Research. Employees of Morgan Stanley not involved in the preparation of Morgan Stanley Research may have investments in securities/instruments or derivatives of securities/instruments of companies mentioned and may trade them in ways different from those discussed in Morgan Stanley Research. Derivatives may be issued by Morgan Stanley or associated persons. With the exception of information regarding Morgan Stanley, Morgan Stanley Research is based on public information. Morgan Stanley makes every effort to use reliable, comprehensive information, but we make no representation that it is accurate or complete. We have no obligation to tell you when opinions or information in Morgan Stanley Research change apart from when we intend to discontinue equity research coverage of a subject company. Facts and views presented in Morgan Stanley Research have not been reviewed by, and may not reflect information known to, professionals in other Morgan Stanley business areas, including investment banking personnel. Morgan Stanley Research personnel may participate in company events such as site visits and are generally prohibited from accepting payment by the company of associated expenses unless pre-approved by authorized members of Research management. Morgan Stanley may make investment decisions that are inconsistent with the recommendations or views in this report. To our readers based in Taiwan or trading in Taiwan securities/instruments: Information on securities/instruments that trade in Taiwan is distributed by Morgan Stanley Taiwan Limited ("MSTL"). Such information is for your reference only. The reader should independently evaluate the investment risks and is solely responsible for their investment decisions. Morgan Stanley Research may not be distributed to the public media or quoted or used by the public media without the express written consent of Morgan Stanley. Any non-customer reader within the scope of Article 7-1 of the Taiwan Stock Exchange Recommendation Regulations accessing and/or receiving Morgan Stanley Research is not permitted to provide Morgan Stanley Research to any third party (including but not limited to related parties, affiliated companies and any other third parties) or engage in any activities regarding Morgan Stanley Research which may create or give the appearance of creating a conflict of interest. Information on securities/instruments that do not trade in Taiwan is for informational purposes only and is not to be construed as a recommendation or a solicitation to trade in such securities/instruments. MSTL may not execute transactions for clients in these securities/instruments. Morgan Stanley is not incorporated under PRC law and the research in relation to this report is conducted outside the PRC. Morgan Stanley Research does not constitute an offer to sell or the solicitation of an offer to buy any securities in the PRC. PRC investors shall have the relevant qualifications to invest in such securities and shall be responsible for obtaining all relevant approvals, licenses, verifications and/or registrations from the relevant governmental authorities themselves. Neither this report nor any part of it is intended as, or shall constitute, provision of any consultancy or advisory service of securities investment as defined under PRC law. Such information is provided for your reference only. Morgan Stanley Research is disseminated in Brazil by Morgan Stanley C.T.V.M. S.A.; in Mexico by Morgan Stanley México, Casa de Bolsa, S.A. de C.V which is regulated by Comision Nacional Bancaria y de Valores. Paseo de los Tamarindos 90, Torre 1, Col. Bosques de las Lomas Floor 29, Mexico City; in Japan by Morgan Stanley MUFG Securities Co., Ltd. and, for Commodities related research reports only, Morgan Stanley Capital Group Japan Co., Ltd; in Hong Kong by Morgan Stanley Asia Limited (which accepts responsibility for its contents) and by Morgan Stanley Asia International Limited, Hong Kong Branch; in Singapore by Morgan Stanley Asia (Singapore) Pte. (Registration number Z) and/or Morgan Stanley Asia (Singapore) Securities Pte Ltd (Registration number H), regulated by the Monetary Authority of Singapore (which accepts legal responsibility for its contents and should be contacted with respect to any matters arising from, or in connection with, Morgan Stanley Research) and by Morgan Stanley Asia International Limited, Singapore Branch (Registration number T11FC0207F); in Australia to "wholesale clients" within the meaning of the Australian Corporations Act by Morgan Stanley Australia Limited A.B.N , holder of Australian financial services license No , which accepts responsibility for its contents; in Australia to "wholesale clients" and "retail clients" within the meaning of the Australian Corporations Act by Morgan Stanley Wealth Management Australia Pty Ltd (A.B.N , holder of Australian financial services license No , which accepts responsibility for its contents; in Korea by Morgan Stanley & Co International plc, Seoul Branch; in India by Morgan Stanley India Company Private Limited; in Indonesia by PT. Morgan Stanley Sekuritas Indonesia; in Canada by Morgan Stanley Canada Limited, which has approved of and takes responsibility for its contents in Canada; in Germany by Morgan Stanley Bank AG, Frankfurt am Main and Morgan Stanley Private Wealth Management Limited, Niederlassung Deutschland, regulated by Bundesanstalt fuer Finanzdienstleistungsaufsicht (BaFin); in Spain by Morgan Stanley, S.V., S.A., a Morgan Stanley group company, which is supervised by the Spanish Securities Markets Commission (CNMV) and states that Morgan Stanley Research has been written and distributed in accordance with the rules of conduct applicable to financial research as established under Spanish regulations; in the US by Morgan Stanley & Co. LLC, which accepts responsibility for its contents. Morgan Stanley & Co. International plc, authorized by the Prudential Regulatory Authority and regulated by the Financial Conduct Authority and the Prudential Regulatory Authority, disseminates in the UK research that it has prepared, and approves solely for the purposes of section 21 of the Financial Services and Markets Act 2000, research which has been prepared by any of its affiliates. RMB Morgan Stanley Proprietary Limited is a member of the JSE Limited and regulated by the Financial Services Board in South Africa. RMB Morgan Stanley Proprietary Limited is a joint venture owned equally by Morgan Stanley International Holdings Inc. and RMB Investment Advisory (Proprietary) Limited, which is wholly owned by FirstRand Limited. The information in Morgan Stanley Research is being disseminated by Morgan Stanley Saudi Arabia, regulated by the Capital Market Authority in the Kingdom of Saudi Arabia, and is directed at Sophisticated investors only. The information in Morgan Stanley Research is being communicated by Morgan Stanley & Co. International plc (DIFC Branch), regulated by the Dubai Financial Services Authority (the DFSA), and is directed at Professional Clients only, as defined by the DFSA. The financial products or financial services to which this research relates will only be made available to a customer who we are satisfied meets the regulatory criteria to be a Professional Client. The information in Morgan Stanley Research is being communicated by Morgan Stanley & Co. International plc (QFC Branch), regulated by the Qatar Financial Centre Regulatory Authority (the QFCRA), and is directed at business customers and market counterparties only and is not intended for Retail Customers as defined by the QFCRA. As required by the Capital Markets Board of Turkey, investment information, comments and recommendations stated here, are not within the scope of investment advisory activity. Investment advisory service is provided exclusively to persons based on their risk and income preferences by the authorized firms. Comments and recommendations stated here are general in nature. These opinions may not fit to your financial status, risk and return preferences. For this reason, to make an investment decision by relying solely to this information stated here may not bring about outcomes that fit your expectations. 16

Video March 1, StratTV at the TMT Conference. Watch the video: Related Research

Video March 1, StratTV at the TMT Conference. Watch the video: Related Research March 1, 2016 Video StratTV at the TMT Conference MORGAN STANLEY & CO. LLC Adam S. Parker, Ph.D. Adam.Parker@morganstanley.com Video March 1, 2016 +1 212 761-1755 Watch the video: Related Research US Equity

More information

Can P-VOD Save Hollywood?

Can P-VOD Save Hollywood? July 10, 2017 09:00 AM GMT Video Media Can P-VOD Save Hollywood? MORGAN STANLEY & CO. LLC Benjamin Swinburne, CFA EQUITY ANALYST Benjamin.Swinburne@morganstanley.com +1 212 761-7527 Watch the video: Related

More information

Interview with CFO Stephen Nolan

Interview with CFO Stephen Nolan March 31, 2016 Video Vista Outdoor Inc. Interview with CFO Stephen Nolan MORGAN STANLEY & CO. LLC Jay Sole Jay.Sole@morganstanley.com +1 212 761-5866 Watch the video: Stephen M. Nolan is Chief Financial

More information

Who s Using XBRL Data & Why: Case Studies

Who s Using XBRL Data & Why: Case Studies M O R G A N S T A N L E Y R E S E A R C H North America Accounting & Valuation Todd Castagno, CFA, CPA Equity Strategist Todd.Castagno@morganstanley.com +1 212 761 6893 Morgan Stanley does and seeks to

More information

January TIC Data Update: Overseas Investors Decreased Agency MBS by $3.6bn

January TIC Data Update: Overseas Investors Decreased Agency MBS by $3.6bn March 15, 2016 Agency MBS Brief January TIC Data Update: Overseas Investors Decreased Agency MBS by $3.6bn MORGAN STANLEY & CO. LLC Michael H Ortiz Michael.Ortiz@morganstanley.com Devan K Knoetze Devan.Knoetze@morganstanley.com

More information

Tobacco Pricing Power Far From Extinguished

Tobacco Pricing Power Far From Extinguished January 14, 2016 Video Global Insight Tobacco Pricing Power Far From Extinguished Our affordability deep dive suggests sustained visibility to 5%+ global pricing, with surprisingly high affordability in

More information

Deep Discount Cigarette Share Gains Elevate Pricing Concerns

Deep Discount Cigarette Share Gains Elevate Pricing Concerns August 1, 2018 04:01 AM GMT Tobacco Deep Discount Cigarette Share Gains Elevate Pricing Concerns Deep discount share increased 70 bps in 2Q18. Widening Marlboro price gaps and MO share losses (-70 bps

More information

Research Tactical Idea

Research Tactical Idea March 1, 2017 10:14 PM GMT Santos Research Tactical Idea Stock Rating Overweight Industry View In-Line Price Target A$5.08 We believe the share price will rise in absolute terms over the next 60 days.

More information

Steel March 15, Mid-Quarter Guidance Preview: Looking

Steel March 15, Mid-Quarter Guidance Preview: Looking March 15, 2016 Steel Mid-Quarter Guidance Preview: Looking for a Beat from STLD We have updated our estimates ahead of mid-quarter guidance likely out later this week and next. Our STLD estimates are comfortably

More information

2018 Hong Kong Summit Feedback

2018 Hong Kong Summit Feedback March 7, 2018 06:33 AM GMT NagaCorp 2018 Hong Kong Summit Feedback MORGAN STANLEY ASIA LIMITED+ Praveen K Choudhary EQUITY ANALYST Praveen.Choudhary@morganstanley.com Jeremy An RESEARCH ASSOCIATE Jeremy.An@morganstanley.com

More information

1st Take: FDA wants to educate US physicians about the basics of biosimilars

1st Take: FDA wants to educate US physicians about the basics of biosimilars October 24, 2017 11:11 PM GMT Celltrion Inc. 1st Take: FDA wants to educate US physicians about the basics of biosimilars Stock Rating Underweight Industry View In-Line Price Target W80,000 The FDA has

More information

Lowering Outlook Following 3Q, Merger Filing Forecast

Lowering Outlook Following 3Q, Merger Filing Forecast November 24, 2015 Cablevision Systems Lowering Outlook Following 3Q, Merger Filing Forecast MORGAN STANLEY & CO. LLC Benjamin Swinburne, CFA Benjamin.Swinburne@morganstanley.com Ryan Fiftal Ryan.Fiftal@MorganStanley.com

More information

ASEAN4 Most Productive Companies

ASEAN4 Most Productive Companies July 29, 2015 Video ASEAN Equity Strategy ASEAN4 Most Productive Companies ASEAN equity strategist Hozefa Topiwalla discusses ASEAN4's Most Productive Companies framework, which could potentially help

More information

First Take: Building on the core

First Take: Building on the core March 27, 2017 10:20 PM GMT FAR Ltd First Take: Building on the core Stock Rating Overweight Industry View In-Line Price Target A$0.13 FAR has announced a farm-in deal with Erin Energy. The deal expands

More information

Our Thoughts On the Preannouncement

Our Thoughts On the Preannouncement October 14, 2015 Manitowoc Co Inc Our Thoughts On the Preannouncement Industry View In-Line Stock Rating Overweight This evening, MTW provided preliminary 3Q15 results, and expects to report net sales

More information

Making the Right Moves in Sports Betting

Making the Right Moves in Sports Betting August 1, 2018 02:05 AM GMT MGM Resorts International Making the Right Moves in Sports Betting Stock Rating Overweight Industry View In-Line Price Target $38.00 Over the course of two days, MGM has announced

More information

Proposed China Tariff on US Pork Negative for HRL/TSN

Proposed China Tariff on US Pork Negative for HRL/TSN March 23, 2018 01:32 01:46 PM GMT Protein Proposed China Tariff on US Pork Negative for HRL/TSN China's potential 25% tariff on US pork represents a meaningful headwind to HRL's profitability. Despite

More information

SHARED AUTONOMY. Adam Jonas, CFA Apple is covered by Katy Huberty; Google is covered by Brian Nowak

SHARED AUTONOMY. Adam Jonas, CFA Apple is covered by Katy Huberty; Google is covered by Brian Nowak SHARED AUTONOMY Adam Jonas, CFA Adam.Jonas@morganstanley.com +1 212 761-1726 Apple is covered by Katy Huberty; Google is covered by Brian Nowak Morgan Stanley does and seeks to do business with companies

More information

1Q16 EPS Above Lowered Expectations

1Q16 EPS Above Lowered Expectations May 4, 2016 Allstate Corporation 1Q16 EPS Above Lowered Expectations MORGAN STANLEY & CO. LLC Kai Pan Kai.Pan@MorganStanley.com Chai Gohil Chaitanya.Gohil@morganstanley.com Allstate Corporation May 4,

More information

3Q15: The Inevitable "Bump in the Road" Quarter

3Q15: The Inevitable Bump in the Road Quarter October 15, 2015 Netflix Inc 3Q15: The Inevitable "Bump in the Road" Quarter MORGAN STANLEY & CO. LLC Benjamin Swinburne, CFA Benjamin.Swinburne@morganstanley.com Thomas Yeh Thomas.Yeh@morganstanley.com

More information

XL Group PLC February 3, 2016

XL Group PLC February 3, 2016 February 3, 2016 XL Group PLC 4Q15: Underlying EPS Miss; Integration On Track MORGAN STANLEY & CO. LLC Kai Pan Kai.Pan@MorganStanley.com Chai Gohil Chaitanya.Gohil@morganstanley.com XL Group PLC February

More information

Sinisi's Shop Food Retail Pricing Study (Vol. 45, August '18)

Sinisi's Shop Food Retail Pricing Study (Vol. 45, August '18) August 1, 2018 04:01 AM GMT Food Retailers Sinisi's Shop Food Retail Pricing Study (Vol. 45, August '18) Whole Foods pricing was +0.3% m/m and -2.0% y/y for Sinisi's Shop basket in our eleventh check post-amazon

More information

No Substitute for Execution; Remain OW

No Substitute for Execution; Remain OW July 23, 2015 Thermo Fisher Scientific Inc. No Substitute for Execution; Remain OW MORGAN STANLEY & CO. LLC Steve Beuchaw Steve.Beuchaw@morganstanley.com Michael Clerico Michael.Clerico@morganstanley.com

More information

Paradise. 4Q13: In line with consensus

Paradise. 4Q13: In line with consensus ASIA/PACIFIC Morgan Stanley & Co. International plc, Seoul Branch+ HyunTaek Lee HyunTaek.Lee@morganstanley.com +82 2 399 9854 Morgan Stanley Asia Limited+ Praveen K Choudhary Praveen.Choudhary@morganstanley.com

More information

In the Penalty Box But Valuation Remains Compelling

In the Penalty Box But Valuation Remains Compelling March 16, 2016 Connecture Inc In the Penalty Box But Valuation Remains Compelling Industry View In-Line Stock Rating Overweight Price Target $7.00 CNXR shares are in the penalty box after missing 4Q revenue

More information

USD Sensitivity. Source: Getty Images

USD Sensitivity. Source: Getty Images September 19, 2014 US Economics USD Sensitivity The nominal trade-weighted major currencies USD index has jumped by more than 3% since early June. We find that a sustained increase of 10% hampers US GDP

More information

Visa Inc. February 29, 2016

Visa Inc. February 29, 2016 February 29, 2016 Visa Inc. Visa at MS TMT Conference: Cautious on macro near-term, but unchanged growth drivers long-term Industry View In-Line Stock Rating Overweight Price Target $90.00 Staying cautious

More information

Canadian Pacific Railway Ltd. (CP.N) Closed Research Tactical Idea

Canadian Pacific Railway Ltd. (CP.N) Closed Research Tactical Idea NORTH AMERICA Morgan Stanley & Co. LLC William J. Greene, CFA William.Greene@morganstanley.com +1 212 761 8017 (CP.N) Closed Research Tactical Idea Effective immediately, the Tactical Idea published on

More information

More Visibility on FY After Q1 Upside, But Valuation Now Appropriate

More Visibility on FY After Q1 Upside, But Valuation Now Appropriate February 3, 2016 Edgewell Personal Care More Visibility on FY After Q1 Upside, But Valuation Now Appropriate Industry View In-Line Stock Rating Equal-weight Price Target $87.00 We remain Equal-weight on

More information

1st Take: November Sales On Track Despite YoY Decline

1st Take: November Sales On Track Despite YoY Decline December 12, 2016 12:16 PM GMT Toung Loong Textile 1st Take: November Sales On Track Despite YoY Decline Stock Rating Overweight Industry View In-Line Price Target NT$110.00 Toung Loong Textile (TLT) reported

More information

2018 Guidance Reduction Sets an Achievable Bar

2018 Guidance Reduction Sets an Achievable Bar July 19, 2018 11:28 PM GMT Philip Morris International Inc 2018 Guidance Reduction Sets an Achievable Bar Stock Rating Overweight Industry View In-Line Price Target $102.00 Q2 results reflected improved

More information

Slower near-term momentum but we expect long-term targets to be reached in OW

Slower near-term momentum but we expect long-term targets to be reached in OW November 16, 2015 International Flavors & Fragrances Slower near-term momentum but we expect long-term targets to be reached in 2016 - OW Industry View In-Line Stock Rating Overweight Price Target US$130.00

More information

March 22, Facing Headwinds

March 22, Facing Headwinds March 22, 2016 Starz Facing Headwinds Industry View Cautious Stock Rating Equal-weight Price Target $32.00 MORGAN STANLEY & CO. LLC Ryan Fiftal Ryan.Fiftal@MorganStanley.com Benjamin Swinburne, CFA Benjamin.Swinburne@morganstanley.com

More information

Kohl's May 14, Not So Great 1Q; Bull Thesis Fading

Kohl's May 14, Not So Great 1Q; Bull Thesis Fading May 14, 2015 Kohl's Not So Great 1Q; Bull Thesis Fading MORGAN STANLEY & CO. LLC Kimberly C Greenberger Kimberly.Greenberger@morganstanley.com Lauren Cassel Lauren.Cassel@morganstanley.com +1 212 761-6284

More information

Price/Earnings Ratios, Risk Premiums and the g* Adjustment

Price/Earnings Ratios, Risk Premiums and the g* Adjustment April 23, 2018 02:18 PM GMT Portfolio Strategy Price/Earnings Ratios, Risk Premiums and the g* Adjustment MORGAN STANLEY & CO. LLC Martin Leibowitz PORTFOLIO ANALYST Martin.Leibowitz@morganstanley.com

More information

2017 Results Largely In Line

2017 Results Largely In Line March 26, 2018 07:03 PM GMT Sinotrans Limited 2017 Results Largely In Line Stock Rating Overweight Industry View In-Line Price Target HK$6.60 Sinotrans 2017 net profit of Rmb2,304mn missed MSe by 2%, but

More information

Solid F3Q Results, a New Bundle Emerges

Solid F3Q Results, a New Bundle Emerges May 5, 2016 21st Century Fox Solid F3Q Results, a New Bundle Emerges MORGAN STANLEY & CO. LLC Benjamin Swinburne, CFA Benjamin.Swinburne@morganstanley.com Thomas Yeh Thomas.Yeh@morganstanley.com +1 212

More information

Earnings Observations: EPS Beats Driving Outsized Moves, Where to Go from Here

Earnings Observations: EPS Beats Driving Outsized Moves, Where to Go from Here August 3, 2015 Business & Education Services Earnings Observations: EPS Beats Driving Outsized Moves, Where to Go from Here Sticking with our top calls: VRSK Overweight, IHS Underweight. What's new: Last

More information

Acquisition of Lafarge/Holcim assets

Acquisition of Lafarge/Holcim assets February 2, 2015 CRH Acquisition of Lafarge/Holcim assets Industry View In-Line Stock Rating ++ CRH is the buyer of the Lafarge/Holcim assets. CRH has announced the acquisition of all of the assets as

More information

Healthcare Premium Priced In

Healthcare Premium Priced In August 2, 2015 IMS Health Holdings Inc Healthcare Premium Priced In Industry View In-Line Stock Rating Equal-weight Price Target $31.00 MORGAN STANLEY & CO. LLC Toni Kaplan Toni.Kaplan@morganstanley.com

More information

Strong Underlying Metrics Point To Upside Potential

Strong Underlying Metrics Point To Upside Potential May 4, 2016 Healthcare Realty Trust Inc. Strong Underlying Metrics Point To Upside Potential MORGAN STANLEY & CO. LLC Vikram Malhotra Vikram.Malhotra@morganstanley.com Landon Park Landon.Park@morganstanley.com

More information

Field Trip Takeaways: Sustained Focus on Network Efficiency

Field Trip Takeaways: Sustained Focus on Network Efficiency January 7, 2018 05:27 PM GMT ZTO Express Field Trip Takeaways: Sustained Focus on Network Efficiency Stock Rating Overweight Industry View In-Line Price Target US$21.20 MORGAN STANLEY ASIA LIMITED+ Edward

More information

Portfolio Strategy. The Endowment Model: Theory and More Experience

Portfolio Strategy. The Endowment Model: Theory and More Experience NORTH AMERICA Morgan Stanley & Co. Incorporated Martin Leibowitz Martin.Leibowitz@morganstanley.com +1 (1)212 761 7597 Anthony Bova Anthony.Bova@morganstanley.com +1 (1)212 761 3781 The Endowment Model:

More information

The Worst Behind Them; Raising PT, Upgrade to EW

The Worst Behind Them; Raising PT, Upgrade to EW November 24, 2015 Schnitzer Steel Industries The Worst Behind Them; Raising PT, Upgrade to EW MORGAN STANLEY & CO. LLC Evan L Kurtz, CFA Evan.Kurtz@morganstanley.com Piyush Sood Piyush.Sood@morganstanley.com

More information

New Pipeline Investment Supportive, But We Still See Downside to Consensus

New Pipeline Investment Supportive, But We Still See Downside to Consensus February 4, 2016 Laclede Group Inc New Pipeline Investment Supportive, But We Still See Downside to Consensus Industry View In-Line Stock Rating Underweight Price Target $62.00 Yesterday Laclede Group

More information

1st Take: OJK suspends new account opening

1st Take: OJK suspends new account opening March 22, 2017 04:34 AM GMT Bank Tabungan Negara 1st Take: OJK suspends new account opening Stock Rating Overweight Industry View In-Line Price Target Rp2,102 OJK suspension: Kontan newspaper today reported

More information

Nike Inc. October 15, 2015

Nike Inc. October 15, 2015 October 15, 2015 Nike Inc. Very Bullish Analyst Day; Nike Remains Our Top Pick MORGAN STANLEY & CO. LLC Jay Sole Jay.Sole@morganstanley.com Joseph Wyatt, CFA Joseph.Wyatt@morganstanley.com Nike Inc. October

More information

Research Tactical Idea

Research Tactical Idea May 26, 2017 10:58 AM GMT Jinko Solar Research Tactical Idea Stock Rating Underweight Industry View Attractive Price Target US$16.40 We believe the share price will fall in absolute terms over the next

More information

CTSH: Is The Bar Low Enough?

CTSH: Is The Bar Low Enough? October 27, 2016 04:02 AM GMT Cognizant Technology Solutions Corp CTSH: Is The Bar Low Enough? Stock Rating Overweight Industry View Cautious Price Target $61.00 MORGAN STANLEY & CO. LLC Brian Essex, CFA

More information

Should We Be Concerned About Industrial Exposure?

Should We Be Concerned About Industrial Exposure? January 25, 2016 Mettler-Toledo International Inc. Should We Be Concerned About Industrial Exposure? MORGAN STANLEY & CO. LLC Steve Beuchaw Steve.Beuchaw@morganstanley.com Michael Clerico Michael.Clerico@morganstanley.com

More information

ACCC, A4ANZ, BARA & BARNZ vs Airports, MQA in the ASX100

ACCC, A4ANZ, BARA & BARNZ vs Airports, MQA in the ASX100 March 10, 2017 12:19 AM GMT Australia Infrastructure ACCC, A4ANZ, BARA & BARNZ vs Airports, MQA in the ASX100 The ACCC has flagged it will seek additional price regulation powers at the next review of

More information

4Q15 Miss: Yet Refiners Hit Seasonal Inflection

4Q15 Miss: Yet Refiners Hit Seasonal Inflection February 24, 2016 HollyFrontier Corporation 4Q15 Miss: Yet Refiners Hit Seasonal Inflection MORGAN STANLEY & CO. LLC Evan Calio Evan.Calio@morganstanley.com Benny Wong Benny.Wong@morganstanley.com +1 212

More information

Weaker NPAT, driven by higher. formation; LDR over 100%

Weaker NPAT, driven by higher. formation; LDR over 100% October 18, 2016 02:28 PM GMT The Siam Commercial Bank Public Company Weaker NPAT, driven by higher loan loss, rise in new NPL formation; LDR over 100% Stock Rating Equal-weight Industry View In-Line Price

More information

Emergency Liquidity Assistance in the Euro Area

Emergency Liquidity Assistance in the Euro Area Emergency Liquidity Assistance in the Euro Area November 2010 Laurence Mutkin Head of European Interest Rate Strategy Laurence.Mutkin@morganstanley.com Morgan Stanley & Co. International plc+ Rachael Featherstone

More information

Indra May 12, Problem contracts & elections drive significant 1Q15 shortfall. Problem contracts and elections falling away drove a topline miss

Indra May 12, Problem contracts & elections drive significant 1Q15 shortfall. Problem contracts and elections falling away drove a topline miss May 12, 2015 Indra Problem contracts & elections drive significant 1Q15 shortfall MORGAN STANLEY & CO. INTERNATIONAL PLC+ Adam Wood Adam.Wood@morganstanley.com Sid Mehra Sid.Mehra@morganstanley.com William

More information

The Robotic Dilemma. Do surgical robots equate to an existential dilemma for SN's orthopedics business? Overweight. Attractive.

The Robotic Dilemma. Do surgical robots equate to an existential dilemma for SN's orthopedics business? Overweight. Attractive. March 21, 2017 05:00 AM GMT Smith & Nephew The Robotic Dilemma Stock Rating Overweight Industry View Attractive Price Target 1,301p Do surgical robots equate to an existential dilemma for SN's orthopedics

More information

7 Key Takes from Meetings with SFM Management

7 Key Takes from Meetings with SFM Management March 16, 2016 Sprouts Farmers Market Inc 7 Key Takes from Meetings with SFM Management MORGAN STANLEY & CO. LLC Vincent J Sinisi Vincent.Sinisi@morganstanley.com Andrew R Ruben Andrew.Ruben@morganstanley.com

More information

2Q16: External Pressures Return

2Q16: External Pressures Return July MONTH 28, 2016 DD, YYYY 01:35 HH:MM AM GMTAM/PM GMT Marriott International Inc. 2Q16: External Pressures Return Stock Rating Equal-weight Industry View In-Line Price Target $73.00 MAR reported 2Q

More information

BorsodChem MDI Suspension Likely to Further Boost Market Sentiment; Positive for Wanhua

BorsodChem MDI Suspension Likely to Further Boost Market Sentiment; Positive for Wanhua August 15, 2017 04:40 PM GMT Wanhua Chemical BorsodChem MDI Suspension Likely to Further Boost Market Sentiment; Positive for Wanhua Stock Rating Overweight Industry View Attractive Price Target Rmb41.46

More information

Corporate Travel Survey 2018 Stronger Trends: Intra-EU & Asia Are Key Drivers

Corporate Travel Survey 2018 Stronger Trends: Intra-EU & Asia Are Key Drivers November 15, 2017 05:00 AM GMT Airlines Corporate Travel Survey 2018 Stronger Trends: Intra-EU & Asia Are Key Drivers In this report we summarise the key observations from our 2018 AlphaWise Corporate

More information

PASPA Overturned: US Sports Betting To Open Up

PASPA Overturned: US Sports Betting To Open Up May 14, 2018 02:33 PM GMT US Sports Betting PASPA Overturned: US Sports Betting To Open Up The US Supreme Court has ruled that PASPA, the law which prohibits states from legalising sports betting, is unconstitutional.

More information

Green Dot Corp February 25, 2016

Green Dot Corp February 25, 2016 February 25, 2016 Green Dot Corp 4Q15: The Six Step Program MORGAN STANLEY & CO. LLC Vasundhara Govil Vasundhara.Govil@morganstanley.com Danyal Hussain, CFA Danyal.Hussain@morganstanley.com +1 212 761-3609

More information

Q Conference October 18 th, 2006 Santa Barbara, CA

Q Conference October 18 th, 2006 Santa Barbara, CA Martin Leibowitz martin.leibowitz@morganstanley.com +1 (212) 761-7597 Anthony Bova anthony.bova@morganstanley.com +1 (212) 761-3781 Q Conference October 18 th, 2006 Santa Barbara, CA Morgan Stanley does

More information

Industry Analysis. BRICs and Motors

Industry Analysis. BRICs and Motors Equity Research Europe BRICs and Motors Adam M. Jonas, CFA European Auto Analyst adam.jonas@morganstanley.com +44 207 425 2177 Industry Analysis EMs account for 80 to >100% of unit growth EMs already account

More information

1st Take: Stronger than Expected December Shipments Thanks to Upturn

1st Take: Stronger than Expected December Shipments Thanks to Upturn January 11, 2015 TCL Communication 1st Take: Stronger than Expected December Shipments Thanks to Upturn in China Industry View In-Line Stock Rating Overweight TCLC reported December smartphone shipments

More information

Model Updates. March 15, Healthcare Services & Distribution MORGAN STANLEY RESEARCH. Ashley E Ponce

Model Updates. March 15, Healthcare Services & Distribution MORGAN STANLEY RESEARCH. Ashley E Ponce March 15, 2016 LH + DGX Model Updates We are updating our models and extending estimates to 2018 - when we think PAMA will likely affect pricing vs. previous estimate of 2017. Trim LH PT to $133, remain

More information

Baby Steps. Equal-weight. Attractive

Baby Steps. Equal-weight. Attractive July MONTH 28, 2016 DD, YYYY 04:01 HH:MM AM GMT AM/PM GMT Care.com Baby Steps Stock Rating Equal-weight Industry View Attractive Price Target $9.50 CRCM has improved profitability, making us more optimistic

More information

Coffee Talk: A Look at February US Scanner Data

Coffee Talk: A Look at February US Scanner Data March 8, 2016 Food and Restaurants Coffee Talk: A Look at February US Scanner Data Total coffee sales contracted 0.2% L4W, a deceleration from +1.7% L12W as both R&G (-3.5%) and K-Cup (+6.0%) trends softened.

More information

March 22, Is An Ultra-Bear Scenario in Play?

March 22, Is An Ultra-Bear Scenario in Play? March 22, 2016 ESRX Is An Ultra-Bear Scenario in Play? Industry View In-Line Stock Rating Equal-weight Price Target $67.00 With ANTM/ESRX dispute escalating to litigation, probability of contract renewal

More information

4Q15 Earnings Preview

4Q15 Earnings Preview January 26, 2016 Cummins Inc. 4Q15 Earnings Preview Industry View In-Line Stock Rating Underweight Price Target $71.00 We forecast a $0.04 miss vs. consensus and expect CMI to provide a 2016e framework

More information

Letter from New York. In-Line. Equal-weight $ What's new: we hosted a day of investor meetings in NY with Dunkin Brand CFO Paul Carbone.

Letter from New York. In-Line. Equal-weight $ What's new: we hosted a day of investor meetings in NY with Dunkin Brand CFO Paul Carbone. October 27, 2016 04:02 AM GMT Dunkin Brands Group Inc Letter from New York Stock Rating Equal-weight Industry View In-Line Price Target $48.00 Coffee focus, product innovation and reduced food complexity

More information

Some Puts and Takes in Q2; Thesis Unchanged, Stay EW

Some Puts and Takes in Q2; Thesis Unchanged, Stay EW August 30, 2018 02:15 AM GMT Dick's Sporting Goods Some Puts and Takes in Q2; Thesis Unchanged, Stay EW Stock Rating Equal-weight Industry View In-Line Price Target $35.00 Q2 EPS beat on better margins

More information

Balanced Portfolio and Gross Margin Upside Drive 1Q Results

Balanced Portfolio and Gross Margin Upside Drive 1Q Results May 4, 2016 CDW Corporation Balanced Portfolio and Gross Margin Upside Drive 1Q Results MORGAN STANLEY & CO. LLC Katy L. Huberty, CFA Kathryn.Huberty@morganstanley.com Jerry Liu Jerry.Y.Liu@morganstanley.com

More information

1Q Report Doesn't Answer Main Question; Stay EW

1Q Report Doesn't Answer Main Question; Stay EW August 3, 2015 Deckers Outdoor Corp 1Q Report Doesn't Answer Main Question; Stay EW MORGAN STANLEY & CO. LLC Jay Sole Jay.Sole@morganstanley.com Joseph Wyatt, CFA Joseph.Wyatt@morganstanley.com +1 212

More information

Mixed Bag in 2Q, Array Growth Accelerates

Mixed Bag in 2Q, Array Growth Accelerates July MONTH 27, 2016 DD, YYYY 07:00 HH:MM AM GMT AM/PM GMT Illumina Inc. Mixed Bag in 2Q, Array Growth Accelerates Stock Rating Underweight Industry View In-Line Price Target $115.00 Sequencing growth was

More information

GoPro Inc January 13, 2016

GoPro Inc January 13, 2016 January 13, 2016 GoPro Inc Picture Not Likely to Clear Up for a While Industry View Cautious Stock Rating Underweight Price Target $12.00 The to-do list is long (better usability, new cameras, etc.), inventories

More information

Prudent Bet On Low Oil Prices

Prudent Bet On Low Oil Prices March 16, 2016 Tsakos Energy Navigation LTD Prudent Bet On Low Oil Prices MORGAN STANLEY & CO. LLC Fotis Giannakoulis Fotis.Giannakoulis@morganstanley.com Sherif Elmaghrabi Sherif.Elmaghrabi@morganstanley.com

More information

Raiffeisen International

Raiffeisen International EUROPE Morgan Stanley & Co. International Limited+ Maciej J Szczesny Maciej.Szczesny@morganstanley.com +44 (0)20 7425 8828 Stock Rating Underweight Industry View No Rating 2Q 06 Results Preview Quick Comment:

More information

Upbeat Tone in Barcelona - Questions

Upbeat Tone in Barcelona - Questions November 16, 2015 Telecom Services Upbeat Tone in Barcelona - Questions for US Carriers This week's European TMT conference in Barcelona featured a record attendance amidst a generally upbeat overall tone.

More information

Global Strategy Forum: Renaissance Meets Reality

Global Strategy Forum: Renaissance Meets Reality Morgan Stanley & Co. LLC : Renaissance Meets Reality Introduction: In today s Strategy Forum we look at the conclusions of the latest Morgan Stanley Blue Paper, US Manufacturing Renaissance: Is It a Masterpiece

More information

5 Telco Questions Ahead of MS SF TMT Conference

5 Telco Questions Ahead of MS SF TMT Conference February 25, 2016 Telecom Services 5 Telco Questions Ahead of MS SF TMT Conference MORGAN STANLEY & CO. LLC Simon Flannery Simon.Flannery@morganstanley.com Lisa Lam, CFA Lisa.Lam@morganstanley.com Spencer

More information

Tower Tour Reinforces Our Positive View on the Towers

Tower Tour Reinforces Our Positive View on the Towers May 15, 2015 Telecom Services Tower Tour Reinforces Our Positive View on the Towers MORGAN STANLEY & CO. LLC Simon Flannery Simon.Flannery@morganstanley.com Armintas Sinkevicius, CFA, CPA Armintas.Sinkevicius@morganstanley.com

More information

Expect a Slight EPS Miss, But Revenue Miss Could be the Bigger Story

Expect a Slight EPS Miss, But Revenue Miss Could be the Bigger Story July 23, 2015 Aramark Holdings Corporation Expect a Slight EPS Miss, But Revenue Miss Could be the Bigger Story MORGAN STANLEY & CO. LLC Denny Galindo, CFA Denny.Galindo@morganstanley.com Toni Kaplan Toni.Kaplan@morganstanley.com

More information

CAR Inc. May 18, 2016

CAR Inc. May 18, 2016 May 18, 2016 CAR Inc. 1Q16 adjusted net income misses weaker short-term rentals MORGAN STANLEY ASIA LIMITED+ Lin He Lin.He@morganstanley.com CAR Inc. May 18, 2016 +852 2239-7597 Industry View In-Line Stock

More information

Structural Headwinds Likely Continue Beyond 2017

Structural Headwinds Likely Continue Beyond 2017 March 1, 2016 Halyard Health Structural Headwinds Likely Continue Beyond 2017 MORGAN STANLEY & CO. LLC David R. Lewis David.R.Lewis@morganstanley.com Jonathan L Demchick Jonathan.Demchick@morganstanley.com

More information

Strong 4Q15 Results. Stock Rating Equal-weight. Price target $7.50. Industry View In-Line

Strong 4Q15 Results. Stock Rating Equal-weight. Price target $7.50. Industry View In-Line February 29, 2016 Scorpio Tankers Inc. Strong 4Q15 Results MORGAN STANLEY & CO. LLC Fotis Giannakoulis Fotis.Giannakoulis@morganstanley.com Sherif Elmaghrabi Sherif.Elmaghrabi@morganstanley.com +1 212

More information

Tax Reform Still at the Drawing Board

Tax Reform Still at the Drawing Board November 3, 2017 12:22 AM GMT US Public Policy Brief Tax Reform Still at the Drawing Board Takeaways: Outcomes skew toward modest stimulus with execution risk; a controversial international system; limited

More information

Growth Story On Track; Near-Term Momentum Seems Sustainable

Growth Story On Track; Near-Term Momentum Seems Sustainable March 30, 2016 Ulta Salon Cosmetics and Fragrance Inc Growth Story On Track; Near-Term Momentum Seems Sustainable Industry View In-Line Stock Rating Equal-weight Price Target $205.00 Investor meetings

More information

IHS Inc. March 9, 2016

IHS Inc. March 9, 2016 March 9, 2016 IHS Inc. Driving Down Ests on Negative Capex Revisions MORGAN STANLEY & CO. LLC Toni Kaplan Toni.Kaplan@morganstanley.com Denny Galindo, CFA Denny.Galindo@morganstanley.com Patrick Halfmann

More information

2Q16 Review: The UnCarrier Continues

2Q16 Review: The UnCarrier Continues July MONTH 28, 2016 DD, YYYY 04:01 HH:MM AM GMT AM/PM GMT T-Mobile US, Inc. 2Q16 Review: The UnCarrier Continues Stock Rating Overweight Industry View Cautious Price Target $52.00 T-Mobile reported strong

More information

Our Thoughts on Biosimilar hype

Our Thoughts on Biosimilar hype October 18, 2017 03:35 PM GMT Celltrion Inc. Our Thoughts on Biosimilar hype Stock Rating Underweight Industry View In-Line Price Target W80,000 Celltrion Group stocks' rallies have drawn interest from

More information

How Fast Will They Grow in 2Q?

How Fast Will They Grow in 2Q? May 4, 2016 Priceline Group Inc How Fast Will They Grow in 2Q? Industry View Attractive Stock Rating Equal-weight Price Target $1,330 MORGAN STANLEY & CO. LLC Brian Nowak, CFA Brian.Nowak@morganstanley.com

More information

NagaCorp March 19, 2015

NagaCorp March 19, 2015 March 19, 2015 NagaCorp Walk around Phnom Penh MORGAN STANLEY ASIA LIMITED+ Alex Poon Alex.Poon@morganstanley.com Praveen K Choudhary Praveen.Choudhary@morganstanley.com +852 3963-3838 +852 2848-5068 Industry

More information

Ctrip.com December 11, 2015

Ctrip.com December 11, 2015 December 11, 2015 Ctrip.com Priceline and Another Firm Each Invest US$500mn in CTRP via CB Industry View Attractive Exhibit 1: CTRP's CB issued to PCLN Source: Company data, Morgan Stanley Research (E)

More information

Highly Levered In A Rising Market

Highly Levered In A Rising Market May 14, 2015 Teekay Tankers Ltd. Highly Levered In A Rising Market Industry View In-Line Stock Rating Equal-weight Price Target $7.50 As tanker rates are booming, TNK offers favorable leverage with a high

More information

IT Hardware February 29, 2016

IT Hardware February 29, 2016 February 29, 2016 IT Hardware TMT Conference: Takeaways from Day 1 We hosted Fitbit, Western Digital, Seagate, and Electronics for Imaging on Day 1 of the MS TMT conference. Key takeaways from company

More information

GPhA thoughts and highlights: further consolidation appears inevitable

GPhA thoughts and highlights: further consolidation appears inevitable February 25, 2016 Specialty Pharmaceuticals GPhA thoughts and highlights: further consolidation appears inevitable We attended the annual GPhA (Generic Pharmaceutical Association) meeting in Florida Feb

More information

RenaissanceRe February 4, 2016

RenaissanceRe February 4, 2016 February 4, 2016 RenaissanceRe Solid 2015 but 2016 Guidance Lowered MORGAN STANLEY & CO. LLC Kai Pan Kai.Pan@MorganStanley.com Chai Gohil Chaitanya.Gohil@morganstanley.com RenaissanceRe February 4, 2016

More information